secwatch.observer — SEC 8-K summary
======================================

Issuer:     INSULET CORP (PODD)
CIK:        0001145197
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001145197-24-000021
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Insulet Q1 revenue $441.7M (+23% YoY); raises full-year guidance
----------------------------------------------------------------

- Q1 revenue $441.7M, +23.3% YoY, above guidance of 17-20% constant currency; Omnipod revenue $433.0M.
- Net income $51.5M ($0.73 diluted EPS) vs $23.8M ($0.34) prior year; operating margin 12.9% (up 520 bps).
- Gross margin 69.5% (up 230 bps); adjusted EBITDA $89.2M (20.2% of revenue) up from 13.6%.
- Raised full-year guidance; launched Omnipod 5 with Dexcom G7 in US and with Abbott/Sensor of Choice in Europe.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1145197/000114519724000021/0001145197-24-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1145197/000114519724000021/podd-20240509.htm
  HTML page:      https://secwatch.observer/filing/0001145197-24-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer